News
- Author:
- Sara Freeman
Publish date: May 6, 2021
From the Europe-based REUMAVID study to the United Kingdom’s CONTAIN study, some common themes are emerging, with lessons to be learned for future ...
News
- Author:
- Sara Freeman
Publish date: May 3, 2021
Almost 75% of patients continued treatment at 6 months, and updated safety findings from the baricitinib clinical development program show no new s...
News
- Author:
- Sara Freeman
Publish date: April 29, 2021
Findings from the largest prospective study of rituximab for NPSLE to date show signs of rituximab’s efficacy in reducing neuropsychiatric disease ...
News
- Author:
- Sara Freeman
Publish date: April 27, 2021
The risk for serious infection seen with tocilizumab is confounded by whether the drug is given as first-line or as subsequent treatment in the lin...
News
- Author:
- Sara Freeman
Publish date: April 16, 2021
Promising data show that detecting a viral gene in Lyme disease–causing bacteria can distinguish between early and late infection.
News
- Author:
- Sara Freeman
Publish date: April 7, 2021
Almost 20% of lung cancer patients in a U.K. study had their radiotherapy dose or fractionation schedule changed during the first wave of the pande...
News
- Author:
- Sara Freeman
Publish date: April 1, 2021
Adding camrelizumab to chemotherapy improved survival in patients with squamous non–small cell lung cancer.
News
- Author:
- Sara Freeman
Publish date: March 29, 2021
Stereotactic body radiotherapy for ultra-central lung tumors offers good disease control and survival but carries a risk of lung hemorrhage.
News
- Author:
- Sara Freeman
Publish date: March 29, 2021
Phase 1/2 results with adagrasib confirm KRAS G12C as a druggable target in non–small cell lung cancer.
News
- Author:
- Sara Freeman
Publish date: March 15, 2021
Researchers have used single-cell analytic techniques to reveal pathologic RA synovial tissue differences in stromal and immune cells between group...
News
- Author:
- Sara Freeman
Publish date: March 3, 2021
There were no improvements in survival when everolimus was added to hormone therapy.
News
- Author:
- Sara Freeman
Publish date: February 26, 2021
The Stop Osteoarthritis program is currently testing the feasibility of a three-part intervention to help prevent posttraumatic knee OA.
News
- Author:
- Sara Freeman
Publish date: February 23, 2021
Both the physical and mental health of people with psoriasis and psoriatic arthritis has been affected by the ongoing COVID-19 pandemic.
News
- Author:
- Sara Freeman
Publish date: February 5, 2021
COVID-19 Global Rheumatology Alliance physician registry data highlight need to maintain adequate disease control to lower risk for death from COVI...
News
- Author:
- Sara Freeman
Publish date: January 12, 2021
Phase 3 results do not support use of entinostat in advanced breast cancer.
